FULGENT GENETICS, INC. Available-for-sale Securities
FULGENT GENETICS, INC. (FLGT) had Available-for-sale Securities of $34.41 million as of 2018-06-30, per its 10-Q filed 2018-08-13.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2018-08-13
- 2018-06-30: Available-for-sale Securities $34.41M.
- 2018-03-31: Available-for-sale Securities $34.39M.
- 2017-12-31: Available-for-sale Securities $34.88M.
- 2017-09-30: Available-for-sale Securities $34.43M.
| Period end | Available-for-sale Securities |
|---|---|
| 2018-06-30 | $34.41M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $34.39M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $34.88M 10-Q · filed 2018-08-13 |
| 2017-09-30 | $34.43M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $34.64M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $40.27M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $38.57M 10-K · filed 2018-03-20 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |